GuidelineCurrent

GINA 2026 — Global Strategy for Asthma Management and Prevention: 2026 Update

Global Initiative for Asthma, 2026

Current GINA strategy for assessment and treatment of asthma, including acute severe asthma: repeated inhaled short-acting bronchodilator therapy, early systemic corticosteroids, oxygen titrated to target saturation, and IV magnesium for selected severe/nonresponding exacerbations; escalation is guided by clinical trajectory and ventilatory failure.

Conditional recommendationModerate certainty

View source guideline

Clinical Context & Relevant Topics (1)

Disease Reference

Asthma (Severe & Near-Fatal Exacerbation)

Pathophysiology of dynamic hyperinflation, auto-PEEP hemodynamics, stepped acute pharmacotherapy, and ventilator mechanics in status asthmaticus.

View Topic Context →